Quantcast
Home / Opinion / Commentary / Reforming FDA, not price control, is path to cheaper drugs

Reforming FDA, not price control, is path to cheaper drugs

It is easy to see the political allure of “cheap drugs,” but what is often ignored by advocates of market distorting price controls is the long-term impact such policies will have on medical innovation and access.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

 

x

Check Also

redistricting-620

Gerrymandering – the ‘Efficiency Gap’ is too unstable a measure

With such measurement instability, I don’t think the Efficiency Gap measurement can be considered a reliable indicator of the extent of partisan gerrymandering of Arizona election districts.